nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—Ergonovine—ABCB1—adrenal gland cancer	0.0112	0.64	CrCbGaD
Lisuride—Ergotamine—ABCB1—adrenal gland cancer	0.0063	0.36	CrCbGaD
Lisuride—HTR2A—sympathetic nervous system—adrenal gland cancer	0.00456	0.163	CbGeAlD
Lisuride—HTR2A—vein—adrenal gland cancer	0.00426	0.152	CbGeAlD
Lisuride—HTR2A—urine—adrenal gland cancer	0.0025	0.0891	CbGeAlD
Lisuride—CYP3A4—urine—adrenal gland cancer	0.00231	0.0825	CbGeAlD
Lisuride—CYP2D6—urine—adrenal gland cancer	0.00227	0.0812	CbGeAlD
Lisuride—HTR2B—adrenal cortex—adrenal gland cancer	0.00124	0.0442	CbGeAlD
Lisuride—ADRB1—cardiac atrium—adrenal gland cancer	0.00107	0.0382	CbGeAlD
Lisuride—ADRA2C—adrenal cortex—adrenal gland cancer	0.000975	0.0348	CbGeAlD
Lisuride—HTR2B—adrenal gland—adrenal gland cancer	0.000894	0.0319	CbGeAlD
Lisuride—DRD2—pituitary gland—adrenal gland cancer	0.00081	0.0289	CbGeAlD
Lisuride—ADRA2C—cardiac atrium—adrenal gland cancer	0.000806	0.0288	CbGeAlD
Lisuride—HTR1A—adrenal gland—adrenal gland cancer	0.000801	0.0286	CbGeAlD
Lisuride—ADRA2C—pituitary gland—adrenal gland cancer	0.000788	0.0281	CbGeAlD
Lisuride—ADRA2C—adrenal gland—adrenal gland cancer	0.000704	0.0251	CbGeAlD
Lisuride—ADRA2A—gonad—adrenal gland cancer	0.000644	0.023	CbGeAlD
Lisuride—ADRA2A—cardiac atrium—adrenal gland cancer	0.000643	0.023	CbGeAlD
Lisuride—ADRA2A—pituitary gland—adrenal gland cancer	0.000628	0.0224	CbGeAlD
Lisuride—ADRA2A—adrenal gland—adrenal gland cancer	0.000561	0.02	CbGeAlD
Lisuride—HTR2A—gonad—adrenal gland cancer	0.000548	0.0195	CbGeAlD
Lisuride—HTR2A—pituitary gland—adrenal gland cancer	0.000534	0.0191	CbGeAlD
Lisuride—HTR2A—adrenal gland—adrenal gland cancer	0.000477	0.017	CbGeAlD
Lisuride—HTR1B—Signaling Pathways—IGF2—adrenal gland cancer	0.000303	0.000317	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—GNAS—adrenal gland cancer	0.0003	0.000314	CbGpPWpGaD
Lisuride—ADRB1—GPCR downstream signaling—POMC—adrenal gland cancer	0.0003	0.000314	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—POMC—adrenal gland cancer	0.000299	0.000313	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—POMC—adrenal gland cancer	0.000299	0.000313	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—IGF1R—adrenal gland cancer	0.000299	0.000313	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—IGF2—adrenal gland cancer	0.000298	0.000312	CbGpPWpGaD
Lisuride—ADRA2B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000297	0.000311	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—GNAS—adrenal gland cancer	0.000295	0.000309	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CDC42—adrenal gland cancer	0.000295	0.000309	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000295	0.000309	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000293	0.000307	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—BAD—adrenal gland cancer	0.000292	0.000306	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000292	0.000306	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—MEN1—adrenal gland cancer	0.00029	0.000304	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—IGF1R—adrenal gland cancer	0.000288	0.000302	CbGpPWpGaD
Lisuride—HTR1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000287	0.000301	CbGpPWpGaD
Lisuride—HTR2C—GPCR downstream signaling—POMC—adrenal gland cancer	0.000285	0.000299	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—IGF2—adrenal gland cancer	0.000284	0.000298	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000282	0.000295	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—GNAS—adrenal gland cancer	0.000282	0.000295	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—PRKACA—adrenal gland cancer	0.000281	0.000294	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CDC42—adrenal gland cancer	0.000278	0.000291	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—POMC—adrenal gland cancer	0.000278	0.000291	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000275	0.000288	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CDC42—adrenal gland cancer	0.000274	0.000288	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CDC42—adrenal gland cancer	0.000274	0.000288	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000273	0.000286	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—PRKACA—adrenal gland cancer	0.000273	0.000286	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—POMC—adrenal gland cancer	0.000272	0.000285	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—POMC—adrenal gland cancer	0.00027	0.000283	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—POMC—adrenal gland cancer	0.000269	0.000282	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000269	0.000281	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IGF2—adrenal gland cancer	0.000268	0.000281	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—BRAF—adrenal gland cancer	0.000266	0.000279	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—GNAS—adrenal gland cancer	0.000266	0.000278	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—PRKACA—adrenal gland cancer	0.000265	0.000278	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IGF2—adrenal gland cancer	0.000265	0.000277	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IGF2—adrenal gland cancer	0.000265	0.000277	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—GNAS—adrenal gland cancer	0.000265	0.000277	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—GNAS—adrenal gland cancer	0.000262	0.000275	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—GNAS—adrenal gland cancer	0.000262	0.000275	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000261	0.000273	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—ABCB1—adrenal gland cancer	0.00026	0.000272	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000259	0.000272	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—POMC—adrenal gland cancer	0.000259	0.000272	CbGpPWpGaD
Lisuride—DRD5—Signaling by GPCR—EGFR—adrenal gland cancer	0.000258	0.00027	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—TERT—adrenal gland cancer	0.000257	0.00027	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IGF1R—adrenal gland cancer	0.000256	0.000268	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000256	0.000268	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—POMC—adrenal gland cancer	0.000252	0.000264	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—TERT—adrenal gland cancer	0.000252	0.000264	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000252	0.000264	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CDC42—adrenal gland cancer	0.00025	0.000262	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—POMC—adrenal gland cancer	0.000248	0.00026	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—TERT—adrenal gland cancer	0.000248	0.00026	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000248	0.00026	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CDC42—adrenal gland cancer	0.000248	0.00026	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000248	0.000259	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000244	0.000255	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IGF2—adrenal gland cancer	0.000241	0.000253	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CDC42—adrenal gland cancer	0.000239	0.000251	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—GNAS—adrenal gland cancer	0.000239	0.00025	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IGF2—adrenal gland cancer	0.000239	0.00025	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CDC42—adrenal gland cancer	0.000238	0.000249	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.000237	0.000248	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—GNAS—adrenal gland cancer	0.000237	0.000248	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—TERT—adrenal gland cancer	0.000237	0.000248	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000233	0.000244	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CDC42—adrenal gland cancer	0.000231	0.000243	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000231	0.000242	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IGF2—adrenal gland cancer	0.000231	0.000242	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IGF2—adrenal gland cancer	0.000229	0.00024	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	0.000229	0.00024	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000229	0.000239	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CDC42—adrenal gland cancer	0.000228	0.000239	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—GNAS—adrenal gland cancer	0.000227	0.000238	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000225	0.000236	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000225	0.000236	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—BAD—adrenal gland cancer	0.000224	0.000234	CbGpPWpGaD
Lisuride—ADRA2B—Hemostasis—TP53—adrenal gland cancer	0.000223	0.000234	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—TERT—adrenal gland cancer	0.000223	0.000234	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IGF2—adrenal gland cancer	0.000223	0.000234	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000223	0.000234	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000222	0.000232	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000222	0.000232	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—GNAS—adrenal gland cancer	0.000221	0.000232	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—TERT—adrenal gland cancer	0.00022	0.000231	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—TERT—adrenal gland cancer	0.00022	0.000231	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IGF2—adrenal gland cancer	0.00022	0.00023	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—BAD—adrenal gland cancer	0.000219	0.00023	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—GNAS—adrenal gland cancer	0.000218	0.000228	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000216	0.000226	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—BAD—adrenal gland cancer	0.000216	0.000226	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—GNAS—adrenal gland cancer	0.000215	0.000225	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000212	0.000222	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—ABCB1—adrenal gland cancer	0.000211	0.000221	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	0.00021	0.00022	CbGpPWpGaD
Lisuride—ADRA2C—Hemostasis—TP53—adrenal gland cancer	0.000209	0.000218	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000208	0.000218	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000208	0.000218	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000207	0.000217	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—POMC—adrenal gland cancer	0.000206	0.000216	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—BAD—adrenal gland cancer	0.000206	0.000216	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000205	0.000215	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—BRAF—adrenal gland cancer	0.000204	0.000213	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	0.000202	0.000212	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—POMC—adrenal gland cancer	0.000202	0.000212	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	0.000201	0.00021	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—TERT—adrenal gland cancer	0.000201	0.00021	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—BRAF—adrenal gland cancer	0.0002	0.000209	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000199	0.000209	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—POMC—adrenal gland cancer	0.000199	0.000208	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—TERT—adrenal gland cancer	0.000199	0.000208	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—EGFR—adrenal gland cancer	0.000197	0.000207	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000197	0.000207	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—BRAF—adrenal gland cancer	0.000196	0.000206	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000196	0.000205	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—BAD—adrenal gland cancer	0.000194	0.000203	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000193	0.000203	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000193	0.000202	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000192	0.000201	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—TERT—adrenal gland cancer	0.000192	0.000201	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—BAD—adrenal gland cancer	0.000192	0.000201	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—BAD—adrenal gland cancer	0.000192	0.000201	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—TERT—adrenal gland cancer	0.000191	0.0002	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—EGFR—adrenal gland cancer	0.00019	0.000199	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—POMC—adrenal gland cancer	0.00019	0.000199	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000188	0.000197	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—BRAF—adrenal gland cancer	0.000187	0.000196	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—TERT—adrenal gland cancer	0.000186	0.000195	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—TERT—adrenal gland cancer	0.000183	0.000191	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000182	0.00019	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000181	0.00019	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—GNAS—adrenal gland cancer	0.00018	0.000188	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—POMC—adrenal gland cancer	0.000179	0.000188	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—POMC—adrenal gland cancer	0.000178	0.000187	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—BRAF—adrenal gland cancer	0.000177	0.000185	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—POMC—adrenal gland cancer	0.000177	0.000185	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—POMC—adrenal gland cancer	0.000177	0.000185	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000175	0.000184	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—BAD—adrenal gland cancer	0.000175	0.000183	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—BRAF—adrenal gland cancer	0.000174	0.000183	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—BRAF—adrenal gland cancer	0.000174	0.000183	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—BAD—adrenal gland cancer	0.000173	0.000181	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.000173	0.000181	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000171	0.000179	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—TP53—adrenal gland cancer	0.000169	0.000177	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000169	0.000177	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—EGFR—adrenal gland cancer	0.000169	0.000177	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TERT—adrenal gland cancer	0.000168	0.000177	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—BAD—adrenal gland cancer	0.000167	0.000175	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—BAD—adrenal gland cancer	0.000166	0.000174	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	0.000166	0.000174	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—BAD—adrenal gland cancer	0.000162	0.000169	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—POMC—adrenal gland cancer	0.000161	0.000169	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—POMC—adrenal gland cancer	0.000159	0.000167	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—BAD—adrenal gland cancer	0.000159	0.000167	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—BRAF—adrenal gland cancer	0.000159	0.000166	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—BRAF—adrenal gland cancer	0.000157	0.000165	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000155	0.000162	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000154	0.000161	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—POMC—adrenal gland cancer	0.000154	0.000161	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—POMC—adrenal gland cancer	0.000153	0.00016	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000153	0.00016	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—EGFR—adrenal gland cancer	0.000152	0.00016	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—BRAF—adrenal gland cancer	0.000152	0.000159	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—BRAF—adrenal gland cancer	0.000151	0.000158	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TERT—adrenal gland cancer	0.000151	0.000158	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—POMC—adrenal gland cancer	0.000149	0.000156	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000147	0.000154	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000147	0.000154	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—BRAF—adrenal gland cancer	0.000147	0.000154	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—BAD—adrenal gland cancer	0.000147	0.000154	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—POMC—adrenal gland cancer	0.000147	0.000154	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000147	0.000154	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—BRAF—adrenal gland cancer	0.000145	0.000152	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—POMC—adrenal gland cancer	0.000145	0.000152	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	0.000144	0.000151	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000144	0.000151	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000143	0.000149	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—PTGS2—adrenal gland cancer	0.000142	0.000149	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000142	0.000149	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—EGFR—adrenal gland cancer	0.00014	0.000147	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.00014	0.000147	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.000137	0.000144	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000135	0.000142	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—POMC—adrenal gland cancer	0.000135	0.000142	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	0.000133	0.00014	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	0.000133	0.000139	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	0.000131	0.000138	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—BAD—adrenal gland cancer	0.000131	0.000137	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000129	0.000136	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—TP53—adrenal gland cancer	0.000128	0.000134	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000128	0.000134	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000127	0.000133	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000126	0.000132	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000126	0.000132	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—POMC—adrenal gland cancer	0.000121	0.000127	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—BRAF—adrenal gland cancer	0.000119	0.000125	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—EGFR—adrenal gland cancer	0.000117	0.000122	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000116	0.000121	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—PTGS2—adrenal gland cancer	0.000115	0.000121	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000115	0.00012	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—EGFR—adrenal gland cancer	0.000114	0.00012	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000114	0.000119	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000113	0.000118	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—EGFR—adrenal gland cancer	0.000112	0.000118	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00011	0.000115	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000109	0.000114	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—EGFR—adrenal gland cancer	0.000107	0.000112	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000106	0.000111	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000105	0.00011	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—EGFR—adrenal gland cancer	0.000101	0.000106	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—EGFR—adrenal gland cancer	9.98e-05	0.000105	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—EGFR—adrenal gland cancer	9.98e-05	0.000105	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—TP53—adrenal gland cancer	9.8e-05	0.000103	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	9.64e-05	0.000101	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—TP53—adrenal gland cancer	9.59e-05	0.0001	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	9.49e-05	9.94e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—TP53—adrenal gland cancer	9.44e-05	9.89e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—POMC—adrenal gland cancer	9.43e-05	9.88e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GNAS—adrenal gland cancer	9.15e-05	9.59e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—EGFR—adrenal gland cancer	9.1e-05	9.53e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—EGFR—adrenal gland cancer	9.01e-05	9.44e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—TP53—adrenal gland cancer	9.01e-05	9.44e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	8.98e-05	9.41e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—EGFR—adrenal gland cancer	8.7e-05	9.12e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—EGFR—adrenal gland cancer	8.66e-05	9.07e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	8.63e-05	9.04e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—TP53—adrenal gland cancer	8.5e-05	8.9e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—EGFR—adrenal gland cancer	8.42e-05	8.82e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—TP53—adrenal gland cancer	8.38e-05	8.78e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—TP53—adrenal gland cancer	8.38e-05	8.78e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—EGFR—adrenal gland cancer	8.29e-05	8.68e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	7.64e-05	8e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—TP53—adrenal gland cancer	7.64e-05	8e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—TP53—adrenal gland cancer	7.57e-05	7.93e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	7.52e-05	7.88e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	7.52e-05	7.88e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—TP53—adrenal gland cancer	7.31e-05	7.65e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—TP53—adrenal gland cancer	7.27e-05	7.62e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—TP53—adrenal gland cancer	7.07e-05	7.41e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—TP53—adrenal gland cancer	6.96e-05	7.29e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—EGFR—adrenal gland cancer	6.84e-05	7.17e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TP53—adrenal gland cancer	6.41e-05	6.72e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	6.31e-05	6.61e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—POMC—adrenal gland cancer	6.16e-05	6.46e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TP53—adrenal gland cancer	5.74e-05	6.02e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	4.92e-05	5.15e-05	CbGpPWpGaD
